NIOX Group (NIOX) Share Price, News & Analysis

Company Overview

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: 62.64 to 65.80
• 50-Day Range: 58 to 64
• 52-Week Range: 57 to 80
• Volume: 4.12 million shs
• Average Volume: 777,357 shs
• Market Capitalization: £26.98 billion
• P/E Ratio: 2,711.32
• Dividend Yield: 1.52%
• Price Target: N/A
• Consensus Rating: N/A

NIOX Stock Analysis - Frequently Asked Questions

How have NIOX shares performed this year?

NIOX Group's stock was trading at GBX 63 at the beginning of 2025. Since then, NIOX shares have increased by 2.2% and is now trading at GBX 64.40.
View the best growth stocks for 2025 here.

How do I buy shares of NIOX Group?

Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of NIOX Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NIOX Group investors own include Petrofac (PFC), MICT (MICT), Chemring Group (CHG) and N Brown Group (BWNG).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:NIOX
• CIK: N/A
• Web: investors.niox.com
• Phone: 44 18 6540 5560
• Fax: N/A
• Employees: 92
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.02
• Trailing P/E Ratio: 2,591.65
• Forward P/E Ratio: 53.87
• P/E Growth: N/A
• Net Income: £995.88 million
• Net Margins: 28.21%
• Pretax Margin: N/A
• Return on Equity: 13.29%
• Return on Assets: 3.95%

Debt

• Debt-to-Equity Ratio: 1.10
• Current Ratio: 6.31
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: £3.53 billion
• Price / Sales: 7.31
• Cash Flow: GBX 5.60 per share
• Price / Cash Flow: 11.21
• Book Value: GBX 18.03 per share
• Price / Book: 3.48

Miscellaneous

• Outstanding Shares: 41,071,615,003
• Free Float: N/A
• Market Cap: £25.79 billion
• Optionable: Not Optionable
• Beta: 0.92